June 2017 – An international workshop aimed at examining the state of current science regarding esophageal squamous cell carcinoma. These discussions highlight a series of difficult questions which are recommended to inform and prioritize future research efforts.
International cancer seminars: a focus on esophageal squamous cell carcinoma
G Murphy, C McCormack, B Abedi-Ardekani, M Arnold, MC Camargo, NA Dar, SM Dawsey, A Etemadi, RC Fitzgerald, DE Fleischer, ND Freedman, AM Goldstein, S Gopal, M Hashemian, N Hu, PL Hyland, B Kaimila, F Kamangar, R Malekzadeh, CG Mathew, D Menya, G Mulima, MM Mwachiro, A Mwasamwaja, N Pritchett, YL Qiao, LF Ribeiro-Pinto, M Ricciardone, J Schuz, F Sitas, PR Taylor, K Van Loon, SM Wang, WQ Wei, CP Wild, C Wu, CC Abnet, SJ Chanock, P Brennan
Annals of Oncology
Full text available at Annals of Oncology
Abstract
The International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI) have initiated a series of cancer-focused seminars [Scelo G, Hofmann JN, Banks RE et al. International cancer seminars: a focus on kidney cancer. Ann Oncol 2016; 27(8): 1382-1385]. In this, the second seminar, IARC and NCI convened a workshop in order to examine the state of the current science on esophageal squamous cell carcinoma etiology, genetics, early detection, treatment, and palliation, was reviewed to identify the most critical open research questions. The results of these discussions were summarized by formulating a series of ‘difficult questions’, which should inform and prioritize future research efforts.